Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Bio-UV Group SAS is a pioneering company in the field of water and surface treatment solutions using ultraviolet (UV) technology. Specializing in the disinfection and purification of water, Bio-UV Group offers advanced and eco-friendly systems designed to improve water quality without the use of chemicals. The company serves a variety of sectors, including municipal water treatment, aquaculture, swimming pools, and industrial applications. By leveraging UV technology, Bio-UV Group effectively addresses challenges related to bacteria, viruses, and other pathogens, ensuring safer and cleaner water. The company's innovations are particularly impactful in supporting industries to meet stringent regulatory standards for water safety. Established in 2000 and based in France, Bio-UV Group has expanded its reach internationally, providing sustainable solutions that contribute significantly to the global water infrastructure and environmental protection. Its role in the market showcases the company's commitment to eco-responsibility and technological advancement in water treatment solutions.
Operating margin is thin at 4.33%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue declined 9.3% YoY. The question is whether this is cyclical or a structural shift.
Free cash flow declined 40% versus the prior year, cash generation momentum has weakened.
Profitability & Returns
Revenue (TTM)
€36M
▼ -9.3% YoY
Net Income (TTM)
€836K
▲ +2566.8% YoY
Op. Margin
4.33%
▼ -1.1pp YoY
ROIC
2.35%
▲ +0.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€3M
▼ -39.7% YoY
Op. Cash Flow (TTM)
€5M
▼ -32.8% YoY
Net Debt
€10M
Cash & Equiv.
€10M
3Y CAGR: -11.2%
3Y CAGR: +84.5%
Continue Research